HologicFRA:HO1 57 FCF Margin % is 18.59% as of Dec. 2025, which is 16% below its 10-year median of 22.21. GuruFocus rates FRA:HO1 with a GF Score™ of 57/100 and a GF Value™ of €70.17. The stock has 4 warning signs investors should review. Among 815 Medical Devices & Instruments companies, Hologic ranks better than 94.23% on this metric.
FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Hologic's Free Cash Flow for the
three
months ended in Dec. 2025 was €166 Mil. Hologic's Revenue for the
three
months ended in Dec. 2025 was €895 Mil. Therefore, Hologic's FCF Margin % for the quarter that ended in Dec. 2025 was 18.59%.
The historical rank and industry rank for Hologic's FCF Margin % or its related term are showing as below:
FRA:HO1'
s FCF Margin % Range Over the Past 10 Years
Min: -3.25 Med: 22.21 Max: 41.1
Current: 23.01
During the past 13 years, the highest FCF Margin % of Hologic was 41.10%. The lowest was -3.25%. And the median was 22.21%.
FRA:HO1's FCF Margin % is ranked better than 94.23% of 815
companies
in the Medical Devices & Instruments industry
Industry Median: -0.03
vs FRA:HO1: 23.01
Hologic FCF Margin % Related Terms
Hologic FCF Margin % Historical Data
* Premium members only.
The historical data trend for Hologic's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:HO1 vs WST, COO, ALGN: FCF Margin % Comparison
For the Medical Instruments & Supplies subindustry, Hologic's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hologic FCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Hologic's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Hologic's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hologic (FRA:HO1) has a FCF Margin % of 18.59% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Hologic and its competitors. This is 16% below median its historical median of 22.21. According to the industry distribution chart, Hologic ranks #47 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 5.8%.
Is Hologic's FCF Margin % too high?
Hologic's current FCF Margin % of 18.59% is 16% below median its 10-year median of 22.21. Based on the distribution chart, Hologic ranks #47 out of 815 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Hologic has a GF Score™ of 57/100, reflecting its overall financial health beyond just this single metric.
How does Hologic's FCF Margin % compare to WST and COO?
According to the Medical Devices & Instruments industry distribution chart, Hologic ranks #47 out of 815 companies for FCF Margin %. This places Hologic in the top 6% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Devices & Instruments company?
A good FCF Margin % depends on the Medical Devices & Instruments industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Hologic and its competitors. Hologic's current FCF Margin % is 18.59%, which is 16% below median its own 10-year median of 22.21. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hologic stock overvalued right now?
Hologic (FRA:HO1) has a current FCF Margin % of 18.59%. The stock's GF Value™ is €70.17, compared to a current price of €65.00 — trading 7.4% below its estimated fair value. The current FCF Margin % is 18.59%, which is 16% below median its 10-year median of 22.21. Hologic's overall GF Score™ is 57/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Hologic (FRA:HO1), the current FCF Margin % is 18.59% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Hologic (FRA:HO1) Overvalued in 2026?
Based on GuruFocus' analysis, Hologic stock appears to be undervalued.
The current stock price of €65.00 is trading 7.4% below its estimated GF Value™ of €70.17.
Key valuation signals for FRA:HO1:
FCF Margin %: 18.59% (16% below median its 10-year median of 22.21)
GF Value™: €70.17 vs. price of €65.00 (7.4% below fair value)
No single metric tells the full story. See the FRA:HO1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.
57GF Score
Get the complete analysis for FRA:HO1
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:HO1 has been successfully added to your 
